IDPALKO Trademark

Trademark Overview


On Wednesday, September 20, 2023, a trademark application was filed for IDPALKO with the United States Patent and Trademark Office. The USPTO has given the IDPALKO trademark a serial number of 79382514. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 26, 2024. This trademark is owned by IO Biotech ApS. The IDPALKO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines
idpalko

General Information


Serial Number79382514
Word MarkIDPALKO
Filing DateWednesday, September 20, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, March 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateMonday, November 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIO Biotech ApS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events


Event DateEvent Description
Wednesday, April 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 5, 2024EXAMINER'S AMENDMENT ENTERED
Monday, February 5, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 5, 2024EXAMINERS AMENDMENT E-MAILED
Monday, February 5, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, January 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 23, 2024REFUSAL PROCESSED BY IB
Saturday, December 30, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, December 30, 2023REFUSAL PROCESSED BY MPU
Wednesday, December 20, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 19, 2023NON-FINAL ACTION WRITTEN
Monday, December 18, 2023ASSIGNED TO EXAMINER
Friday, November 10, 2023APPLICATION FILING RECEIPT MAILED
Monday, November 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB